Article info

Download PDFPDF
Original article
Serum ghrelin is associated with risk of colorectal adenocarcinomas in the ATBC study

Authors

  1. Correspondence to Gwen Murphy, Metabolic Epidemiology Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, 9609 Medical Center Dr, 6E428, Bethesda, MD 20850, USA; murphygw{at}mail.nih.gov
View Full Text

Citation

Murphy G, Cross AJ, Dawsey SM, et al
Serum ghrelin is associated with risk of colorectal adenocarcinomas in the ATBC study

Publication history

  • Received October 5, 2016
  • Revised June 27, 2017
  • Accepted June 28, 2017
  • First published August 16, 2017.
Online issue publication 
August 13, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.